These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3481314)

  • 1. Chemotherapy of otitis media with ofloxacin.
    Lenarz T
    Drugs; 1987; 34 Suppl 1():139-43. PubMed ID: 3481314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin in oral chemotherapy of acute and chronic otitis media.
    Lenarz T
    Infection; 1986; 14 Suppl 4():S324-6. PubMed ID: 3469167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ofloxacin in the conservative therapy of acute and chronic otitis media--a preliminary clinical report of experiences].
    Lenarz T
    Infection; 1986; 14 Suppl 1():S87-8. PubMed ID: 3456987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.
    Klein JO
    Pediatr Infect Dis J; 2001 Jan; 20(1):102-3; discussion 120-2. PubMed ID: 11176586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of ofloxacin in chronic otitis media and chronic sinusitis in adult outpatients.
    Gehanno P; Cohen B
    Eur Arch Otorhinolaryngol; 1993; 250 Suppl 1():S13-4. PubMed ID: 8476579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial treatment of otitis media.
    Giebink GS; Canafax DM
    Semin Respir Infect; 1991 Jun; 6(2):85-93. PubMed ID: 1771307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
    Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ofloxacin in the treatment of Pseudomonas aeruginosa infections of the ear].
    Oberascher G; Karas C
    HNO; 1988 Jun; 36(6):230-3. PubMed ID: 3165974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue concentrations of ofloxacin in the middle ear.
    Thorn V
    Clin Ther; 1987; 9(5):523-7. PubMed ID: 3478138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of antibiotic resistance in material isolated from the middle ear in children with acute otitis media not responding to standard antibiotic treatment].
    Zielnik-Jurkiewicz B; Bielicka A
    Otolaryngol Pol; 2007; 61(5):892-7. PubMed ID: 18552043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experiences with ofloxacin sequential therapy in chronic ear infections.
    Heppt W; Lutz H
    Eur Arch Otorhinolaryngol; 1993; 250 Suppl 1():S19-21. PubMed ID: 8476581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerance of oral ofloxacin in treating various infections.
    Giamarellou H; Tsagarakis J
    Drugs; 1987; 34 Suppl 1():119-23. PubMed ID: 3481312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimicrobial activity of ofloxacin against recent clinical isolates from otitis media and otitis externa].
    Matsumoto Y; Suzuki Y; Ishii Y; Ishihara R; Nakazawa A; Nakane Y; Nishinari C; Deguchi K
    Jpn J Antibiot; 1998 Sep; 51(9):561-75. PubMed ID: 9846283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenic bacteria distribution and drug susceptibility in children with acute otitis media in Pearl River Delta].
    Wen R; Deng Q; Sun C; Gao S; Tao J; Luo R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 25(19):884-7. PubMed ID: 22242472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era.
    Pumarola F; Marès J; Losada I; Minguella I; Moraga F; Tarragó D; Aguilera U; Casanovas JM; Gadea G; Trías E; Cenoz S; Sistiaga A; García-Corbeira P; Pirçon JY; Marano C; Hausdorff WP
    Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1231-6. PubMed ID: 23746414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of pathogens and antimicrobial treatment in different groups of patients with chronic otitis media.
    Kaźmierczak W; Janiak-Kiszka J; Budzyńska A; Nowaczewska M; Kaźmierczak H; Gospodarek-Komkowska E
    J Laryngol Otol; 2022 Mar; 136(3):219-222. PubMed ID: 34702380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial etiology of acute otitis media and clinical efficacy of amoxicillin-clavulanate versus azithromycin.
    Guven M; Bulut Y; Sezer T; Aladag I; Eyibilen A; Etikan I
    Int J Pediatr Otorhinolaryngol; 2006 May; 70(5):915-23. PubMed ID: 16293317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of otitis media.
    Thoene DE; Johnson CE
    Pharmacotherapy; 1991; 11(3):212-21. PubMed ID: 1862012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiology and management of otitis media.
    Brook I; Van de Heyning PH
    Scand J Infect Dis Suppl; 1994; 93():20-32. PubMed ID: 8047854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of ofloxacin into bronchial secretions.
    Symonds J; Bone M; Turner A; Javaid A
    Drugs; 1987; 34 Suppl 1():33-6. PubMed ID: 3481325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.